Grand opening of the i3, with Dr. Dubach, Associate Director of the i3, discussing i3 services, facilities, and equipment. @JimBrinkMD @MGH_RI @MGHImaging
Grand opening of the i3, with Dr. Arnold, Executive Director of the CTRU, describing the collaboration between i3 and IBC to form the CTRU to provide translational clinical research services. @MGH_RI
Grand opening of the i3, with Dr. Caravan, Co-Director of the i3, giving examples of translational work and first-in-man studies. @JimBrinkMD @MGH_RI @MGHImaging@PeterCaravan
In this editorial, Dr. Chen discusses results from the article by Akai et al. on mouse model investigation of gadolinium brain deposition and behavioral testing, as well as the safety and medicolegal impact of these results. bit.ly/3gPgGss@MGHChenLab@HarvardMed
Administration of gadolinium-based contrast agents (GBCAs) in mice showed deposition in deep cerebellar nuclei with linear agents. Behavioral testing on these mice showed no effects on motor activity, anxiety, or memory. bit.ly/3mRFCDj#NeuroRad